Terumo (TSE:4543) and Glooko today announced a collaboration to integrate their technologies and create new diabetes data sharing solutions. In the new technology integration, users with diabetes will be able to transfer recorded data from the Terumo Medisafe With insulin patch pump into the Glooko management platform, allowing for the visualization of insulin dosage, food and activities in […]
Terumo
FDA clears Terumo’s next-gen plasma collection device
Terumo (TSE: 4543) announced today that the FDA cleared its Rika next-generation automated plasma collection system. Lakewood, Colorado-based Terumo designed the Rika system to include safety features that minimize operator errors while collecting plasma in 35 minutes or less. According to a news release, the company developed Rika in response to the industry’s need for […]
Diabeloop, Terumo partner to bring automated insulin delivery to Europe
Diabeloop announced that it entered into an agreement with Terumo with eyes on bringing automated insulin delivery solutions to Europe. Paris-based Diabeloop’s automated insulin delivery (AID) system automates and personalizes the treatment of insulin-dependent diabetes and contributes to reducing the mental burden associated with the metabolic disease. Get the full story at our sister site, Drug […]
FDA committee to examine safety of endovascular stent grafts
FDA’s CDRH Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet later this year to examine the safety of endovascular stent grafts made by Endologix and other companies. Day one of the meeting will examine the benefit-risk profile of the Endologix AFX endovascular graft system regarding a potentially higher-than-expected risk of blood […]
Terumo to acquire Health Outcomes Sciences
Terumo (TSE: 4543) recently announced that it has signed a definitive agreement to acquire all assets of Health Outcomes Sciences. The financial terms of the deal were not disclosed. Phoenix-based HOS is a creator of predictive analytics and clinical decision support software. Its sePRISM content enablement platform is meant to enable healthcare organizations to deliver […]
FDA approves low-profile aneurysm embolization system
Terumo (TYO:4543) subsidiary MicroVention announced today that it received FDA approval of a PMA supplement for its WEB 17 system. Aliso Viejo, Calif.-based MicroVention’s WEB 17 system is a new addition to its WEB aneurysm embolization system for treating intracranial wide-neck bifurcation aneurysms, according to a news release. WEB 17 features a lower profile delivery system compatible […]
MicroVention suing Balt
Terumo (TYO:4543) subsidiary MicroVention announced today that it filed a second lawsuit against Balt USA for trade secret misappropriation. Aliso Viejo, Calif.-based MicroVention’s second lawsuit against Balt and four former employees follows an earlier patent lawsuit that is still ongoing, having been filed in July 2019, according to a news release. MicroVention alleges that, during the discovery […]
How did medtech companies score on environmental stewardship list?
Medical Design & Outsourcing recently rated the world’s largest medical device companies — the Big 100 — for their sales numbers and R&D spend. Now we can share how some of them scored on an environmental nonprofit’s annual list of companies ranked for their actions on climate change. Not-for-profit organization CDP (Stockholm, Sweden) runs a global disclosure system for […]
MedTech 100 roundup: Industry hits pandemic peak
After five months since medtech stocks peaked before the COVID-19 pandemic rocked the markets, the industry inched back toward that pre-pandemic high. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 88.9 points at the end of last week (July 17). That total represents just a -3.7% […]
Terumo acquires Quirem Medical for up to $45m
Terumo (OTC:TRUMY;TYO:4543) announced this week that it has completed the acquisition of Netherlands-based startup Quirem Medical, which is developing microspheres for selective internal radiation therapy (SIRT), a treatment for liver tumors. Under the terms of the agreement, Terumo acquired 80.1% of the shares of Quirem Medical. This is over and above its current share position of 19.9%, […]
Fibralign partners with Terumo
Stanford spin-out Fibralign announced today that it entered into a long-term distributor agreement with Terumo for the BioBridge collagen matrix. The agreement is set to see Terumo market and distribute BioBridge collagen matrix, which is used to treat and prevent secondary lymphedema, in Japan. BioBridge is a sterile, implantable, biocompatible and biodegradable surgical mesh made […]
